Background: There are ambiguous data concerning late LV remodeling following mitral valve surgery due to chronic regurgitation (MR). Methods: We performed serial echocardiographic evaluation of 35 consecutive patients prior and following surgical treatment of mitral valve for chronic regurgitation. Studies were performed 1 week before operation (I), then at 1 week (II) and 9 -13 months (III) (mean 11 months) after surgery. End-diastolic and systolic diameters (LVEDD and LVESD) and left atrial (LA) size were recorded from parasternal longaxis view, and ejection fraction (EF) was calculated by Teicholtz formula. Statistical significance of achieved values was assessed. Materials: The study group consisted of 35 patients (25 males, 10 females, age 63±9 yrs) All pts were symptomatic due to the significant MR: NYHA II (n = 8), III (n = 25), IV (n = 2). All subjects had excluded coronary artery disease by coronary angiogram. 30 patients underwent successful mitral valve replacement without preservation of subvalvular apparatus and 5 mitral valve repair. Results: Echo -Doppler examination before procedure discovered isolated significant MR (4+) with left ventricular dilatation (LVEDD 6.6cm±0.3, LVESD 4.3cm±0.8, left atrial enlargement (6.0 cm±1.1), and pulmonary hypertension (systolic PAP 46 mmHg ± 16). Changes of assessed parameters obtained in consecutive examinations are depicted in table 1. All changes were independent of age, LV size, EF or NYHA status.
6.6 ± 0.3 0.05 6.4 ± 0.3 0.0001 5.7 ± 0.7 0.0001 LVEDS [cm] 4.3 ± 0.8 0.01 4.6 ± 0.5 0.001 4.0 ± 0.6 0.05 EF [%] 61.2 ± 15.3 0.0001 52.0 ± 9.9 0.05 57.2 ± 4.8 0.01 LA [cm] 6.0 ± 1.1 5.2 ± 0.9 0.0001 PAP [mmHg] 46 ± 16 38 ± 15 0.01
Conclusions:
After successful surgical treatment of mild-to-moderate symptomatic chronic MR there is gradual fall in LVEDD implying continued ventricular remodeling over several months. However, we observed increase of LVEDS with subsequent decrease of EF that may support opinion of crucial role of mitral valve apparatus in overall LV performance. EF fall did not preclude, however, reduction of pulmonary hypertension and LA diameter in long-term follow-up. The 30-day mortality was 2.2% (1 pt) while late mortality (up to 6 years) was 20.9% After surgey 74.4% of patients (32 pts) improved at least 1 NYHA functional class. Pre-operative age (67±7 ys vs 71±5 ys; p <0.13), LVEF% (33.3±4.5 vs 31.1±3.6; p=n.s.), NYHA functional class (2.3±1.2 vs 2.0±1.9), simultaneous CABG (4 vs 3; p=n.s.) were not significantly related to late mortality. Conclusions: in our study the ventricular dysfunction seems be related to afterload mismacth. Among select patients with severe aortic stenosis, severe left ventricular dysfunction and a higher preoperative mean gradient, AVR was associated with significantly improved survival. ESE was performed using a modified cycloergometer, in the sitting position; it started with a power output of 25 Watts and increased 25 Watts every 3 minutes; during the test, LV function was monitored from apical 4 chamber view and LV EF was computed at every step. DE was performed using a viability protocol with an initial dose of 5 µg/Kg/min until a maximum dose of 20 µg/Kg/min (increasing every 5 minutes). LV EF was computed at each step. A positive LVCR was defined when a > 30% increase of LV EF was observed, compared to basal value. Results: 8 p showed concordance between ESE and DE (2 with LVCR and 6 without LVCR). In the remaining 8 p (basal LVEF 0.44±0.06), a LV EF increase was observed only during DE (0.61±0.09, p<0.01), whereas during ESE LV EF was stable or decreased (LV EF 0.44±0.07 n.s.).
Conclusions: This preliminary experience shows a discordance between ESE and DE in assessing LVCR in the 50% of p with chronic severe AR and LV dysfunction. It is not possible to determine whether this result can be due to the different accuracies of the tests (is LVCR overestimated by DE or underestimated by ESE?). While waiting for outcome results after surgery in a larger number of p which possibly will assess the predictive role of ESE and DE, we suggest to use both tests in the pre-operative decsion making of p with severe AR and LV systolic dysfunction. Background: The concept of resistance to flow (pressure/flow ratio) has been proposed as a useful parameter for evaluating the hemodynamic consequences of aortic stenosis. However, only limited data exists on non-invasively derived resistance for aortic valve prostheses. The aim of this investigation was to study valvular resistance in homograft valves of different sizes and to analyse this variable in comparison with other haemodynamic indices. Methods: Thirty-one patients were studied at rest and during a symptom-limited supine exercise test. The patients were divided into 4 groups according to the valve size; 18-19 mm (n = 9), 20-21 mm (n = 9), 22-23 mm (n = 8) and 24-27 mm(n = 5). All homografts were inserted in a subcoronary position using a free-hand technique. Maximal (Pmax) and mean (Pmean) pressure difference, effective orifice area (EOA) and valve resistance (R) were calculated at rest and at peak exercise. R (dynes x s x cm-5) was calculated according to the equation R = (1.333 x Pmean)/aortic valve flow. Results: The mean (±SD) workload achieved was 62±26 W. In all groups there was a significant increase in cardiac output, pressure differences and valvular resistance during exercise (p<0.001). EOA did not changed during exercise. There was a considerable overlap in pressure differences between the groups at rest and during exercise and the increase in Pmax from rest to exercise was of the same magnitude. Patients with the 18-19 mm valves showed significantly higher increase in valve resistance from 47.0(12.9) to 60.5(17.2) dynes x s x cm-5 during exercise compared with the other three sizes, 32.1(12. 
